TrialEmerging microbes & infections2023

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial.

Xubin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.